CD28 and CTLA-4 Have Opposing Effects on the Response of T Cells to Stimulation

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1995 Aug 1

PMID 7543139

Citations 818

Authors

M F Krummel

J P Allison

Affiliations

Soon will be listed here.

Abstract

The importance of the B7/CD28/CTLA-4 molecules has been established in studies of antigen-presenting cell-derived B7 and its interaction with the T cell costimulatory molecule CD28. CTLA-4, a T cell surface glycoprotein that is related to CD28, can also interact with B7-1 and B7-2. However, less is known about the function of CTLA-4, which is expressed at highest levels after activation. We have generated an antibody to CTLA-4 to investigate the consequences of engagement of this molecule in a carefully defined system using highly purified T cells. We show here that the presence of low levels of B7-2 on freshly explanted T cells can partially inhibit T cell proliferation, and this inhibition is mediated by interactions with CTLA-4. Cross-linking of CTLA-4 together with the TCR and CD28 strongly inhibits proliferation and IL-2 secretion by T cells. Finally, results show that CD28 and CTLA-4 deliver opposing signals that appear to be integrated by the T cell in determining the response to activation. These data strongly suggest that the outcome of T cell antigen receptor stimulation is regulated by CD28 costimulatory signals, as well as inhibitory signals derived from CTLA-4.

Citing Articles

Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies.

Roussot N, Kaderbhai C, Ghiringhelli F Cancers (Basel). 2025; 17(5).

PMID: 40075753 PMC: 11898530. DOI: 10.3390/cancers17050906.

Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products.

Li D, Lan X, Xu L, Zhou S, Luo H, Zhang X Front Immunol. 2025; 16:1552010.

PMID: 40066456 PMC: 11891355. DOI: 10.3389/fimmu.2025.1552010.

Six events that shaped antibody approvals in oncology.

Paul S, Zhou S Front Immunol. 2025; 16:1533796.

PMID: 39995677 PMC: 11847691. DOI: 10.3389/fimmu.2025.1533796.

The chick embryo chorioallantoic membrane as an experimental model to study immune checkpoint inhibitors.

Ribatti D Intern Emerg Med. 2025; .

PMID: 39966234 DOI: 10.1007/s11739-025-03904-8.

The current landscape of optogenetics for the enhancement of adoptive T-cell therapy.

Smith G, Lee M, Jennings E, James J Discov Immunol. 2025; 4(1):kyae019.

PMID: 39959909 PMC: 11829120. DOI: 10.1093/discim/kyae019.

References

Lane P, GERHARD W, Hubele S, Lanzavecchia A, McConnell F . Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. Immunology. 1993; 80(1):56-61. PMC: 1422105. View

Freeman G, Borriello F, Hodes R, Reiser H, Hathcock K, Laszlo G . Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science. 1993; 262(5135):907-9. DOI: 10.1126/science.7694362. View

Truitt K, Hicks C, Imboden J . Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J Exp Med. 1994; 179(3):1071-6. PMC: 2191424. DOI: 10.1084/jem.179.3.1071. View

Holsti M, McArthur J, Allison J, Raulet D . Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody. J Immunol. 1994; 152(4):1618-28. View

Songyang Z, Shoelson S, McGlade J, Olivier P, Pawson T, Bustelo X . Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol. 1994; 14(4):2777-85. PMC: 358643. DOI: 10.1128/mcb.14.4.2777-2785.1994. View

Damle N, Klussman K, Leytze G, Myrdal S, Aruffo A, Ledbetter J . Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol. 1994; 152(6):2686-97. View

Prasad K, Cai Y, Raab M, Duckworth B, Cantley L, Shoelson S . T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A. 1994; 91(7):2834-8. PMC: 43465. DOI: 10.1073/pnas.91.7.2834. View

Stein P, Fraser J, Weiss A . The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase. Mol Cell Biol. 1994; 14(5):3392-402. PMC: 358704. DOI: 10.1128/mcb.14.5.3392-3402.1994. View

Pages F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J . Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature. 1994; 369(6478):327-9. DOI: 10.1038/369327a0. View

10.

Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y . JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 1994; 77(5):727-36. DOI: 10.1016/0092-8674(94)90056-6. View

11.

August A, DuPont B . CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int Immunol. 1994; 6(5):769-74. DOI: 10.1093/intimm/6.5.769. View

12.

June C, Bluestone J, Nadler L, Thompson C . The B7 and CD28 receptor families. Immunol Today. 1994; 15(7):321-31. DOI: 10.1016/0167-5699(94)90080-9. View

13.

August A, Gibson S, Kawakami Y, Kawakami T, Mills G, DuPont B . CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci U S A. 1994; 91(20):9347-51. PMC: 44809. DOI: 10.1073/pnas.91.20.9347. View

14.

Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier L . B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 1994; 180(5):1841-7. PMC: 2191743. DOI: 10.1084/jem.180.5.1841. View

15.

Inaba K, Inaba M, Hathcock K, Sakuta H, Azuma M, Yagita H . The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med. 1994; 180(5):1849-60. PMC: 2191729. DOI: 10.1084/jem.180.5.1849. View

16.

Schneider H, Prasad K, Shoelson S, Rudd C . CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med. 1995; 181(1):351-5. PMC: 2191832. DOI: 10.1084/jem.181.1.351. View

17.

Walunas T, Lenschow D, Bakker C, Linsley P, Freeman G, Green J . CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994; 1(5):405-13. DOI: 10.1016/1074-7613(94)90071-x. View

18.

Jenkins M . The ups and downs of T cell costimulation. Immunity. 1994; 1(6):443-6. DOI: 10.1016/1074-7613(94)90086-8. View

19.

Green J, Noel P, Sperling A, Walunas T, GRAY G, Bluestone J . Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1994; 1(6):501-8. DOI: 10.1016/1074-7613(94)90092-2. View

20.

Lenschow D, Su G, Zuckerman L, Nabavi N, Jellis C, GRAY G . Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A. 1993; 90(23):11054-8. PMC: 47920. DOI: 10.1073/pnas.90.23.11054. View